You are here: Industry Insights > cancer

News List

As Novartis' other cancer launches struggle, Lutathera gets off to flying start fiercepharma
November 11, 2018
Novartis has stumbled with a couple of its recent cancer launches, namely the complicated CAR-T rollout for Kymriah and come-from-behind Kisqali debut. But not so with Lutathera.
As Novartis' other cancer launches struggle, Lutathera gets off to flying start fiercepharma
November 11, 2018
Novartis has stumbled with a couple of its recent cancer launches, namely the complicated CAR-T rollout for Kymriah and come-from-behind Kisqali debut. But not so with Lutathera.
FDA Approves Udenyca，Udenyca is Coherus’ first drug to receive FDA or EC approval americanpharmaceuticalreviewpharmaceutical-technol
November 10, 2018
Coherus BioSciences announced the U.S. Food and Drug Administration (FDA) has approved Udenyca (pegfilgrastim-cbqv), the first pegfilgrastim biosimilar approved by both the FDA and the European Commission (EC) for patients with cancer receiving myelosuppr
Gap in research means millions living with long-term consequences of cancer worldpharmanews
November 10, 2018
This growing population report side-effects that seriously affect their quality of life, but a combination of a shortage of funding, a lack of clear direction and relatively few researchers with expertise in this area have left a gap in cancer research.
Tumour immune cells could aid cancer therapies worldpharmanew
November 10, 2018
A pioneering technique designed to spot differences between immune cells in tumours could speed the development of cancer treatments, research suggests. Scientists say the approach could be used to help doctors choose the best treatments for individual pa
Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies pharmafocusasia
November 05, 2018
Gilead Sciences, Inc and Tango Therapeutics, Inc., a company focused on the discovery and development of novel cancer therapies...
Barriers to Prostate Cancer Research in Black Men Identified drugs
November 01, 2018
Barriers to Prostate Cancer Research in Black Men Identified
Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. pharmafile
October 31, 2018
Despite being the 7th most common cancer in the United Kingdom, 45% of patients were initially treated for less serious conditions such as urine infections, kidney stones or respiratory problems....
Palbociclib improves patients’ survival in metastatic breast cancer europeanpharmaceuticalreview
October 31, 2018
A Phase III clinical trial has shown that a combination of palbociclib and fulvestrant leads to a longer survival for HR-positive breast cancer…
New epigenetic drug strategy to treat cancer worldpharmanews
October 29, 2018
Researchers have discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page